NR (Nicotinamide Riboside): Tracking a NAD+ Precursor

Nicotinamide Riboside (NR) is a form of vitamin B3 and a precursor to NAD+, a coenzyme involved in mitochondrial energy production and DNA repair. It is sold commercially as Niagen and is one of the two NAD+ precursors most discussed in longevity circles — the other being NMN. Unlike many compounds in this space, NR has been through multiple human safety trials. What it does for healthy adults in measurable terms is a much narrower story.

What it does

NR raises blood NAD+ levels. That part is well-established in clinical pharmacokinetic data. What is far less established:

• Whether higher NAD+ in a healthy adult produces a felt or measurable health benefit
• Whether NR meaningfully outperforms cheaper niacin or nicotinamide
• Whether long-term supplementation changes any hard outcome

If you start NR expecting to feel different next week, you will likely be disappointed and unable to tell whether you are responding.

Typical protocol shape

• Oral capsule, once daily, usually with food
• Continuous dosing rather than cycled — most protocols are open-ended
• Doses in the hundreds of mg range, based on commercial product labeling and published trials

Specifics are not prescriptions — work them out with a clinician.

What to track daily

For a compound with no acute effect, you have to track for trends over months, not days:

• Subjective energy score (1-10) at a fixed time
• Sleep quality
• Exercise tolerance — perceived exertion at a fixed workout
• Mood
• GI tolerance — flushing or stomach upset

What to track weekly

• A standardized exercise metric — heart rate at a fixed pace, or reps at a fixed load
• Resting heart rate (morning)
• HRV if you have a wearable
• Body weight and waist measurement

Peptide IA will plot these as 4-week rolling averages, which is the only honest way to read this kind of data.

Bloodwork worth doing

NR is one of the few peptide-adjacent compounds where bloodwork is a real option:

• NAD+ level (specialty lab) — baseline and at 8-12 weeks
• Fasting glucose and insulin
• Lipid panel
• CBC and CMP
• HbA1c if running long-term

Realistic expectations

Most self-experimenters do not feel NR the way they feel caffeine. Effects, if present, are typically described as a gradual reduction in perceived fatigue at month 2 or 3. A large fraction of users notice nothing despite higher NAD+ on bloodwork. NMN versus NR is largely a debate about absorption and cost — there is no clear winner in head-to-head outcome data.

Common mistakes

1. Stopping after two weeks because nothing happened. This is not a two-week compound.
2. Stacking with NMN, resveratrol, and pterostilbene at the same time. You will never know which one did what.
3. No baseline bloodwork. If you are spending money on a longevity supplement, spend a fraction of it on a blood panel first.
4. Conflating "NAD+ went up" with "I am healthier." They are not the same claim.

A tracking template

Week 0: baseline blood panel, two weeks of daily metrics. Weeks 1-12: daily dose, daily and weekly metrics. Week 12: repeat blood panel.

Read the lab deltas alongside the subjective trend. If neither moved, your money is better spent elsewhere.

Bottom line

NR is one of the safer and better-studied supplements in the longevity space, but "well-studied for safety" is not the same as "proven to do something for you." Track it like a long experiment, not a stimulant.

Peptide IA is an educational and self-tracking tool. Nothing in this post is medical advice. Doses mentioned reflect what is commonly reported in research literature — they are not recommendations. Always consult a qualified physician before starting, changing, or stopping any protocol.